BioCentury | Feb 13, 2021
Deals
Feb. 12 Quick Takes: NexImmune, Decibel rise in NASDAQ debuts; plus Sagimet’s $80M crossover, Forbion launches VectorY, Aurora Science leads InteRNA round and a SPAC for Sharecare
...By Jeff Cranmer, Executive Editor Shares of NexImmune Inc. (NASDAQ:NEXI) and Decibel Therapeutics Inc. (NASDAQ:DBTX) traded higher Friday...
...while immunotherapy play NexImmune raised $110 million through the sale of 6.5 million shares at $17. NexImmune...
...initial enterprise value of $3.9 billion with about $400 million in capital. Jeff Cranmer Forbion Capital Partners Decibel Therapeutics NexImmune Sagimet...
...while immunotherapy play NexImmune raised $110 million through the sale of 6.5 million shares at $17. NexImmune...
...initial enterprise value of $3.9 billion with about $400 million in capital. Jeff Cranmer Forbion Capital Partners Decibel Therapeutics NexImmune Sagimet...